A

Aligos Therapeutics

82 employees

Aligos is a biopharmaceutical company developing targeted therapeutics to address unmet medical needs in liver and viral diseases including MASH, CHB and COVID-19.

Investor insights

Funding rounds participated in

$105M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology

Sectors

Biotechnology

Date founded

2018

Funding rounds raised

Total raised

$105M

from investors over 1 rounds

A

Aligos Therapeutics raised $105M on March 12, 2025